MOVE trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes MOVE achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, Corvex, Inc. (MOVE) has a Wall Street consensus price target of N/A, based on estimates from 4 covering analysts. The company has a market capitalization of $23.28B.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, MOVE trades at a trailing P/E of -34.4x. Analysts expect EPS to grow -96093.7% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MNMDMind Medicine (MindMed) Inc. | $3.2B | $42.79 | $20.00 | -53.3% | Buy | — | 1 |
 AEYEAudioEye, Inc. | $92M | $7.37 | — | — | — | — | — |
 BWAYBrainsWay Ltd. | $566M | $14.43 | $17.00 | +17.8% | Buy | 47.0x | 6 |
 GRMNGarmin Ltd. | $55.6B | $288.55 | $320.25 | +11.0% | Hold | 28.8x | 28 |
 FITBFifth Third Bancorp | $49.7B | $54.89 | $62.13 | +13.2% | Buy | 17.9x | 51 |
 DXCMDexCom, Inc. | $34.4B | $89.16 | $89.71 | +0.6% | Buy | 33.5x | 52 |
 ABTAbbott Laboratories | $202.3B | $116.13 | $123.64 | +6.5% | Buy | 21.1x | 41 |
 SENSSenseonics Holdings, Inc. | $398M | $9.52 | $13.33 | +40.0% | Buy | — | 17 |
 PODDInsulet Corp. | $9.9B | $143.05 | $185.18 | +29.5% | Buy | 22.0x | 50 |
 LIVNLivaNova PLC | $4.4B | $79.41 | $87.67 | +10.4% | Buy | 18.3x | 15 |
Quick answers to the most common questions about buying MOVE stock.
The consensus price target for MOVE is $N/A, close to the current price of $9.29 (N/A% implied move). Based on 4 analyst estimates, the stock appears fairly valued near current levels.
MOVE has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
MOVE's current price is $9.29 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $N/A for MOVE, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
MOVE is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month MOVE stock forecast based on 4 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy".
MOVE appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
MOVE analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.